Business
Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has come” at the CPhI annual report press conference and recent investors in the technology echo his words.
'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI
Share:
Listens: 0